"A new prescription for negative claim limitations"

by Dr. Hailey Bureau | World IP Review

Dr. Hailey Bureau was recently published in World IP Review’s latest digital edition of World IP Review. In her article, “A new prescription for negative claim limitations,” Dr. Bureau discusses the CAFC’s precedential reversal in Novartis Pharms Corp v Accord Healthcare (Fed Cir, June 21, 2022) in regard to negative claim limitations. Dr. Bureau writes, “Not only does this decision raise the standard for written description support for negative limitations, but it also raises a unique procedural issue.” Check out the rest of the article linked below!

Full Article

Tags: CAFC Infringement Intellectual Property Pharmaceutical Written Description

Contact Us